Showing 1061-1070 of 3082 results for "".
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c
Medical Marijuana: Composition, Neurological Benefits, And Adverse Events
https://practicalneurology.com/diseases-diagnoses/headache-pain/medical-marijuana-composition-neurological-benefits-and-adverse-events/30512/Exploring the potential benefits of medical marijuana in neurology and future directions in care.Oculopharyngeal Muscular Dystrophy: Key Clinical Features, Genetic Diagnosis, and Management Strategies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/oculopharyngeal-muscular-dystrophy-key-clinical-features-genetic-diagnosis-and-management-strategies/56908/Early identification of oculopharyngeal muscular dystrophy can streamline diagnosis and help address dysphagia-related morbidity, a major driver of quality of life.Inclusion Body Myositis: Diagnosis, Clinical Features, and Emerging Therapies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/inclusion-body-myositis-diagnosis-clinical-features-and-emerging-therapies/56907/Despite limited effective treatments, advances in understanding inclusion body myositis pathophysiology are driving new therapeutic approaches currently under investigation.Managing Mood Disorders, Behavioral Changes, and Psychosis in People Living with Vascular Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/managing-mood-disorders-behavioral-changes-and-psychosis-in-people-living-with-vascular-dementia/36649/This article explores the neuropsychiatric symptoms associated with vascular dementia, including their underlying mechanisms, clinical implications, and potential management strategies.Contemporary Challenges in the Recognition, Diagnosis, and Management of Progressive Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/contemporary-challenges-in-the-recognition-diagnosis-and-management-of-progressive-multiple-sclerosis/31974/There are many challenges associated with identifying the transition to secondary progressive multiple sclerosis.Pay for Performance: Understanding and Preparing for MIPS
https://practicalneurology.com/columns/practice-management/pay-for-performance-understanding-and-preparing-for-mips/30418/As a new reimbursement model is set to unveil, physicians will have a tight window to prepare their practices to begin reporting in 2017.Board Re-Certification: Reform or Reboot
https://practicalneurology.com/columns/practice-management/board-re-certification-reform-or-reboot/30542/A neurologist has been leading the charge to reform MOC in neurology. He talked to Practical Neurology® about the issue.Rising Drug Prices and the Cost of Care: What Can Physicians Do?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/rising-drug-prices-and-the-cost-of-care-what-can-physicians-do/30327/The multiple sclerosis drug market offers a snapshot of a growing problem. Physicians should speak out on behalf of the specialty and their patients.